BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

903 related articles for article (PubMed ID: 25058336)

  • 1. From PET/CT to PET/MRI: advances in instrumentation and clinical applications.
    Hu Z; Yang W; Liu H; Wang K; Bao C; Song T; Wang J; Tian J
    Mol Pharm; 2014 Nov; 11(11):3798-809. PubMed ID: 25058336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomography/magnetic resonance imaging (PET/MRI): An update and initial experience at HC-FMUSP.
    Queiroz MA; Barbosa FG; Buchpiguel CA; Cerri GG
    Rev Assoc Med Bras (1992); 2018 Jan; 64(1):71-84. PubMed ID: 29561945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PET/MRI: Emerging Clinical Applications in Oncology.
    Fraum TJ; Fowler KJ; McConathy J
    Acad Radiol; 2016 Feb; 23(2):220-36. PubMed ID: 26521689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
    Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positron emission tomography/magnetic resonance: Present and future].
    Kohan AA; Vercher Conejero JL; Gaeta MC; Pelegrí Martinez L; Ros PR
    Rev Esp Med Nucl Imagen Mol; 2013; 32(3):167-76. PubMed ID: 23582491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Clinical PET/MRI Instrumentation.
    Herzog H; Lerche C
    PET Clin; 2016 Apr; 11(2):95-103. PubMed ID: 26952724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical PET/MR Imaging in Oncology: Future Perspectives.
    Kjær A; Torigian DA
    PET Clin; 2016 Oct; 11(4):489-93. PubMed ID: 27593252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of time-of-flight PET on quantification errors in MR imaging-based attenuation correction.
    Mehranian A; Zaidi H
    J Nucl Med; 2015 Apr; 56(4):635-41. PubMed ID: 25745090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
    Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
    Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical positron emission tomography/magnetic resonance imaging applications.
    von Schulthess GK; Kuhn FP; Kaufmann P; Veit-Haibach P
    Semin Nucl Med; 2013 Jan; 43(1):3-10. PubMed ID: 23178084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET/MR imaging: technical aspects and potential clinical applications.
    Torigian DA; Zaidi H; Kwee TC; Saboury B; Udupa JK; Cho ZH; Alavi A
    Radiology; 2013 Apr; 267(1):26-44. PubMed ID: 23525716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of female pelvic tumors : Application fields of integrated PET/MRI].
    Grueneisen J; Umutlu L
    Radiologe; 2016 Jul; 56(7):605-11. PubMed ID: 27315240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal imaging approaches: PET/CT and PET/MRI.
    Pichler BJ; Judenhofer MS; Pfannenberg C
    Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An outlook on future design of hybrid PET/MRI systems.
    Zaidi H; Del Guerra A
    Med Phys; 2011 Oct; 38(10):5667-89. PubMed ID: 21992383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR/PET: a new challenge in hybrid imaging.
    Werner MK; Schmidt H; Schwenzer NF
    AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated PET/MR.
    Quick HH
    J Magn Reson Imaging; 2014 Feb; 39(2):243-58. PubMed ID: 24338921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Simultaneous whole-body PET-MRI in pediatric oncology : More than just reducing radiation?].
    Gatidis S; Gückel B; la Fougère C; Schmitt J; Schäfer JF
    Radiologe; 2016 Jul; 56(7):622-30. PubMed ID: 27306199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.